🇺🇸 FDA
Patent

US 8217176

Fused heterocyclic derivative and use thereof

granted A61PA61P35/00A61P35/02

Quick answer

US patent 8217176 (Fused heterocyclic derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00, A61P35/02, A61P35/04, A61P43/00